Abstract
Skeletal Dysplasias discusses these disorders concentrating on clinical and radiographic descriptions, molecular abnormalities, histopathology, lethal variants, orthopedic deformities by region and by specific disease entities, and orthopedic treatments.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parrot J. Sur la malformation achondroplastique et le Dieu Ptah. Bull Soc Anthrop. 1878;1:296–308.
Beighton P, Giedion ZA, Gorlin R, et al. International classification of osteochondrodysplasias. International working group on constitutional diseases of bone. Am J Med Genet. 1992;44(2):223–9.
Rimoin DL. International nomenclature and classification of the osteochondrodysplasias (1997). Am J Med Genet. 1998;79:376–82.
Hall CM. International nosology and classification of constitutional disorders of bone (2001). Am J Med Genet 2002;113(1):65–77.
Superti-Furga A, Unger S. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A. 2007;143(1):1–18.
Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A. 2011;155(5):943–968.
Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J. 1991;5(7):2052–60.
Bailey JA 2nd. Disproprtionate short stature. diagnosis and management. Philadelphia: WB Saunders; 1973.
Rubin P. Dynamic classifications of bone dysplasias. Chicago: Yearbook Medical Publishers; 1964.
Jansen M. Dissociation of bone growth Robert Jones Birthday Volume. London: Humphrey Milford; 1928.
Brailsford JF. The radiology of bones and joints. 4th edn. Londond, J and A Churchill; 1948.
Fairbank T. An Atlas of general affections of the skeleton. Edinburgh: E&S Livingstone; 1951.
Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS, Alanay Y. The skeletal dysplasias: clinical-molecular correlations. Ann N Y Acad Sci. 2007;1117:302–9.
Cohen M Jr. Some chondrodysplasias with short limbs: molecular perspectives. Am J Med Genet. 2002;112:304–13.
Cohen M Jr. The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet Part A. 2006;140A:2646–706.
Goldberg MJ. The dysmorphic child: an orthopedic perspective. New York: Raven Press; 1987.
Jones KL, Jones MC, del Campo M. Smith’s Recognizable Patterns of Human Malformation. 7th ed. Elsevier, Philadelphia; 2013.
Wynne-Davies R, Gormley J. The prevalence of skeletal dysplasias. An estimate of their minimum frequency and the number of patients requiring orthopaedic care. J Bone Joint Surg Br. 1985;67(1):133–7.
Beighton P. Osteochondrodysplasias in South Africa. Am J Med Genet. 1996;63(1):7–11.
Vaara P, Peltonen J, Poussa M, et al. Development of the hip in diastrophic dysplasia. J Bone Joint Surg Br. 1998;80(2):315–20.
Schramm T, Gloning KP, Minderer S, et al. Prenatal sonographic diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol. 2009;34(2):160–70.
Sillence DO, Rimoin DL, Lachman R. Neonatal dwarfism. Pediatr Clin NA. 1978;25:453–83.
Bailey JA 2nd. Forms of dwarfism recognizable at birth. Clin Orthop Relat Res. 1971;76:150–9.
Romero R, Pilu G, Jeanty P, Ghidini A, Hobbins JC. Prenatal diagnosis of congenital anomalies. Norwalk, CT: Appleton & Lange; 1988.
Elejalde BR, de Elejalde MM. The prenatal growth of the human body determined by the measurement of bones and organs by ultrasonography. Am J Med Genet. 1986;24(4):575–98.
Chitty LS, Altman DG, Henderson A, Campbell S. Charts of fetal size: 4. Femur length. Br J Obstet Gynaecol. 1994;101(2):132–5.
Lessoway VA, Schulzer M, Wittmann BK, Gagnon FA, Wilson RD. Ultrasound fetal biometry charts for a North American Caucasian population. J Clin Ultrasound. 1998;26(9):433–53.
De Biasio P, Prefumo F, Lantieri PB, Venturini PL. Reference values for fetal limb biometry at 10-14 weeks of gestation. Ultrasound Obstet Gynecol. 2002;19(6):588–91.
Kurtz AB, Wapner RJ. Ultrasonographic diagnosis of second-trimester skeletal dysplasia: prospective analysis in a high-risk population. J UltrasoundMed. 1983;2(3):99–106.
Hobbins JC, Bracken MB, Mahoney MJ. Diagnosis of fetal skeletal dysplasias with ultrasound. Am J Obstet Gynecol. 1982;142(3):306–12.
Filly RA, Golbus MS, Carey JC, Hall JG. Short-limited dwarfism: ultrasonographic diagnosis by mensuration of fetal femoral length. Radiology. 1981;138:653–6.
Kurtz AB, Filly RA, Wapner RJ, et al. In utero analysis of heterozygous achondroplasia: variable time of onset as detected by femur length measurements. J Ultrasound Med. 1986;5(3):137–40.
Gordienko I, Grechanina E, Sopko NI, Tarapurova EN, Mikchailets LP. Prenatal diagnosis of osteochondrodysplasias in high risk pregnancy. Am J Med Genet. 1996;63(1):90–7.
Parilla BV, Leeth EA, Kambich MP, Chilis P, MacGregor SN. Antenatal detection of skeletal dysplasias. J Ultrasound Med. 2003;22(3):255–258; quiz 259–261.
Witters I, Moerman P, Fryns JP. Skeletal dysplasias: 38 prenatal cases. Genet Couns. 2008;19(3):267–75.
Krakow D, Alanay Y, Rimoin LP, et al. Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis. Am J Med Genet A. 2008;146A(15):1917–24.
Horton WA, Hall JG, Scott CI, Pyeritz RE, Rimoin DL. Growth curves for height for diastrophic dysplasia, spondyloepiphyseal dysplasia congenita, and pseudoachondroplasia. Am J Dis Child. 1982;136(4):316–9.
Horton WA, Rotter JI, Rimoin DL, Scott CI, Hall JG. Standard growth curves for achondroplasia. J Pediatr. 1978;93(3):435–8.
Scott CI Jr. Dwarfism. Clin Symp. 1988;40(1):1–32.
McKusick VA. Heritable disorders of connective tissue. 4th ed. St. Louis: CV Mosby; 1972.
Beighton P. Inherited disorders of the skeleton. 2nd ed. Edinburgh: Churchill Livingston; 1988.
Maroteaux P. Les maladies osseuses De L’Enfant. 3rd ed. Paris: Flammarion; 1995.
Spranger J, Langer L, Wiedemann HR. Bone Dysplasias—an Atlas of constitutional disorders of skeletal development. 1974.
Lorincz AE, Hurst RE, Kolodny EH. The early laboratory diagnosis of mucopolysaccharidoses. Ann Clin Lab Med. 1982;12:258–66.
Frezal J, LeMerrer M, Chauvet ML. Osteochondrodysplasia, dysostoses, disorders of calcium metabolism, congenital malformations with skeletal involvement mapped on human chromosomes. Pediatr Radiol. 1997;27:366–87.
McKusick VA, Amberger JS, Francomano CA. Progress in medical genetics: map-based gene discovery and the molecular pathology of skeletal dysplasias. Am J Med Genet. 1996;63(1):98–105.
Horton WA, Machado MA, Ellard J, et al. Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis. Proc Natl Acad Sci USA. 1992;89(10):4583–7.
Anderson IJ, Goldberg RB, Marion RW, Upholt WB, Tsipouras P. Spondyloepiphyseal dysplasia congenita: genetic linkage to type II collagen (COL2AI). Am J Hum Genet. 1990;46(5):896–901.
Lee B, Vissing H, Ramirez F, Rogers D, Rimoin D. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. Science. 1989;244(4907):978–80.
Newman B, Wallis GA. Skeletal dysplasias caused by a disruption of skeletal patterning and endochondral ossification. Clin Genet. 2003;63:241–51.
Krakow D, Riomoin DL. The skeletal dysplasias. Genet Med. 2010;12(6):327–41.
Rimoin DL. Molecular defects in the chondrodysplasias. Am J Med Genet. 1996;63(1):106–10.
Maroteaux P. Bone dysplasias due to abnormalities in type II collagen. Rev Rhum Engl Ed. 1998;65(4):221–4.
Mundlos S, Olsen BR. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J. 1997;11(2):125–32.
Mundlos S, Olsen BR. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J. 1997;11(4):227–33.
Superti-Furga A, Bonafe L, Rimion DL. Molecular-pathogenetic classification of genetic disorders of the skeleton. Am J Med Genet. 2001;106:282–93.
Winter RM. Recent molecular advances in dysmorphology. Hum Mol Genet. 1995;4 Spec No:1699–1704.
Spranger J. Bone dysplasia ‘families’. Pathol Immunopathol Res. 1988;7(1–2):76–80.
Cohen MM Jr. Short-limb skeletal dysplasias and craniosynostosis: what do they have in common? Pediatr Radiol. 1997;27(5):442–6.
Muenke M, Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 1995;11(8):308–13.
Webster MK, Donoghue DJ. FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 1997;13(5):178–82.
Tavormina PL, Shiang R, Thompson LM, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet. 1995;9(3):321–8.
Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995;56(2):368–73.
Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994;371(6494):252–4.
Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78(2):335–42.
Horton WA, Machado MA, Chou JW, Campbell D. Achondrogenesis type II, abnormalities of extracellular matrix. Pediatr Res. 1987;22(3):324–9.
Horton WA. Progress in human chondrodysplasias: molecular genetics. Ann N Y Acad Sci. 1996;785:150–9.
Eyre DR, Upton MP, Shapiro FD, Wilkinson RH, Vawter GF. Nonexpression of cartilage type II collagen in a case of Langer-Saldino achondrogenesis. Am J Med Genet. 1985;39:52–67.
Murray LW, Bautista J, James PL, Rimoin DL. Type II collagen defects in the chondrodysplasias. I. Spondyloepiphyseal dysplasias. Am J Hum Genet. 1989;45(1):5–15.
Tiller GE, Weis MA, Polumbo PA, et al. An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita. Am J Hum Genet. 1995;56(2):388–95.
Bogaert R, Wilkin D, Wilcox WR, et al. Expression, in cartilage, of a 7-amino-acid deletion in type II collagen from two unrelated individuals with Kniest dysplasia. Am J Hum Genet. 1994;55(6):1128–36.
Fernandes RJ, Wilkin DJ, Weis MA, et al. Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia. Arch Biochem Biophys. 1998;355(2):282–90.
Spranger J, Menger H, Mundlos S, Winterpacht A, Zabel B. Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia. Pediatr Radiol. 1994;24(6):431–5.
Weis MA, Wilkin DJ, Kim HJ, et al. Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation. J Biol Chem. 1998;273(8):4761–8.
Winterpacht A, Superti-Furga A, Schwarze U, et al. The deletion of six amino acids at the C-terminus of the alpha 1 (II) chain causes overmodification of type II and type XI collagen: further evidence for the association between small deletions in COL2A1 and Kniest dysplasia. J Med Genet. 1996;33(8):649–54.
Kaitila I, Korkko J, Marttinen E, Ala-Kokko L. Phenotypic expressions of a Gly 154Arg mutation in type II collagen in two unrelated patients with spondyloepimetaphyseal dysplasia (SEMD). Am J Med Genet. 1996;63(1):111–22.
Tiller GE, Polumbo PA, Weis MA, et al. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia. Strudwick type. Nat Genet. 1995;11(1):87–9.
Bonnemann CG, Cox GF, Shapiro F, et al. A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc Natl Acad Sci USA. 2000;97(3):1212–7.
Paassilta P, Lohiniva J, Annunen S, et al. COL9A3: A third locus for multiple epiphyseal dysplasia. Am J Hum Genet. 1999;64(4):1036–44.
Warman ML, Abbott M, Apte SS, et al. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet. 1993;5(1):79–82.
Wallis GA, Rash B, Sweetman WA, Thomas JT, Super M, Evans G, Grant ME, Boot-Handford RP. Amnio acid substitutios of conserved residues in the carboxyl-terminal domain of the alpha 1(X) chain of type X collagen occur in 2 unrelated families with metaphyseal chondrodysplasia type Schmid. Am J Hum Genet. 1994;54(2):169–78.
Li Y, Lacerda DA, Warman ML, et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell. 1995;80(3):423–30.
Vikkula M, Mariman EC, Lui VC, et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell. 1995;80(3):431–7.
Hastbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet. 1992;2(3):204–11.
Hastbacka J, de la Chapelle A, Mahtani MM, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell. 1994;78(6):1073–87.
Hastbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES. Sulfate transport in chondrodysplasia. Ann N Y Acad Sci. 1996;785:131–6.
Cai G, Nakayama M, Hiraki Y, Ozono K. Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B. Am J Med Genet. 1998;78(1):58–60.
Superti-Furga A, Hastbacka J, Rossi A, et al. A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. Ann N Y Acad Sci. 1996;785:195–201.
Superti-Furga A, Hastbacka J, Wilcox WR, et al. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet. 1996;12(1):100–2.
Superti-Furga A, Rossi A, Steinmann B, Gitzelmann R. A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations. Am J Med Genet. 1996;63(1):144–7.
Ballo R, Briggs MD, Cohn DH, Knowlton RG, Beighton PH, Ramesar RS. Multiple epiphyseal dysplasia, ribbing type: a novel point mutation in the COMP gene in a South African family. Am J Med Genet. 1997;68(4):396–400.
Briggs MD, Hoffman SM, King LM, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet. 1995;10(3):330–6.
Briggs MD, Mortier GR, Cole WG, et al. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet. 1998;62(2):311–9.
Cohn DH, Briggs MD, King LM, et al. Mutations in the cartilage oligomeric matrix protein (COMP) gene in pseudoachondroplasia and multiple epiphyseal dysplasia. Ann N Y Acad Sci. 1996;785:188–94.
Deere M, Sanford T, Ferguson HL, Daniels K, Hecht JT. Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. Am J Med Genet. 1998;80(5):510–3.
Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FF, Harrison WR, Francomano CA, Prange CK, Lennon GC, Deere M, et al. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet. 1995;10(3):325–9.
Schipani E, Langman CB, Parfitt AM, et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia. N Engl J Med. 1996;335(10):708–14.
Belin V, Cusin V, Viot G, et al. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet. 1998;19(1):67–9.
Shears DJ, Vassal HJ, Goodman FR, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet. 1998;19(1):70–3.
Hopwood JJ, Morris CP. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med. 1990;7(5):381–404.
Smits P, Bolton AD, Funari V, Hong M, Boyden ED, Lu L, Manning DK, Dwyer ND, et al. Lethal skeletal dysplasia in mice and humans lacking the Golgin GMAP-210. New Engl J Med. 2010;362:206–16.
Mundlos S, Otto F, Mundlos C, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997;89(5):773–9.
Bellus GA, McIntosh I, Smith EA, et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet. 1995;10(3):357–9.
Bennett JT, McMurray SW. Stickler syndrome. J Pediatr Orthop. 1990;10(6):760–3.
Matsui Y, Yasui N, Kimura T, Tsumaki N, Kawabata H, Ochi T. Genotype phenotype correlation in achondroplasia and hypochondroplasia. J Bone Joint Surg Br. 1998;80(6):1052–6.
Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet. 1996;33(9):749–52.
Prinster C, Carrera P, Maschio MD, Weber G, Maghnie M, Vigone MC, Mora S, et al. Comparasion of clinical-radiological and molecular findings in hypochondroplasia. Am J Med Genet. 1998;75(1):109–12.
Bonaventure J, Rousseau F, Legeai-Mallet L, Le Merrer M, Munnich A, Maroteaux P. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet. 1996;63(1):148–54.
Cohn DH. Mutations affecting multiple functional domains of FGFR3 cause different skeletal dysplasias: a personal retrospective in honor of John Wasmuth. Ann N Y Acad Sci. 1996;785:160–3.
Nerlich AG, Freisinger P, Bonaventure J. Radiological and histological variants of thanatophoric dysplasia are associated with common mutations in FGFR-3. Am J Med Genet. 1996;63(1):155–60.
Tretter AE, Saunders RC, Meyers CM, et al. Antenatal diagnosis of lethal skeletal dysplasias. Am J Med Genet. 1998;75(5):518–22.
Rasmussen SA, Bieber FR, Benacerraf BR, Lachman RS, Rimoin DL, Holmes LB. Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am J Med Genet. 1996;61(1):49–58.
Sharony R, Browne C, Lachman RS, Rimoin DL. Prenatal diagnosis of the skeletal dysplasias. Am J Obstet Gynecol. 1993;169(3):668–75.
Lachman RS. Fetal imaging in the skeletal dysplasias: overview and experience. Pediatr Radiol. 1994;24(6):413–7.
Maroteaux P, Lamy M, Robert J. Lenanisme thanatophore. Presse Med. 1967;75:2519–24.
Sahinoglu Z, Uludogan M, Gurbuz A, Karateke A. Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities. Arch Gynecol Obstet. 2003;269(1):57–61.
Langer LO Jr, Yang SS, Hall JG, et al. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl. 1987;3:167–79.
Wilcox W, Tavormina PL, Krakow D, et al. Molecular, radiological, and histopathologic correlations in thanatotropic dysplasia. Am J Med Genet. 1998;78:274–81.
Rousseau F, el Ghouzzi V, Delezoide AL, et al. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet. 1996;5(4):509–12.
Karczeski B, Cutting GR. Thanatophoric Dysplasia. Gene Reviews® [Internet] 2004 May 21(updated 2013 Sept 12) In: Pagon RA, Adam MP, Andinger HH et al editors. Gene Reviews. University of Washington: Seattle WA; 1993–2014.
Moskowitz N, Carson B, Kopits S, Levitt R, Hart G. Foramen magnum decompression in an infant with homozygous achondroplasia. Case report. J Neurosurg. 1989;70(1):126–8.
Shapiro F. Consequences of an osteogenesis imperfecta diganosis for survival and ambulation. J Pediatr Orthop. 1985;5:456–62.
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101–16.
Van der Harten HJ, Brons JTJ, Dijkstra PF, et al. Achondrogenesis-hypochondrogenesis: The spectrum of chondrogenesis imperfecta: A radiological, ultrasonographic, and histopathologic study of 23 cases. Pediatr Pathol. 1988;8:571–97.
Sillence D, Worthington S, Dixon J, Osborn R, Kozlowski K. Atelosteogenesis syndromes: a review, with comments on their pathogenesis. Pediatr Radiol. 1997;27(5):388–96.
Farrington-Rock C, Firestein MH, Bicknell LS, et al. Mutations in two regions of FLNB result in atelosteogenesis I and III. Hum Mutat. 2006;27(7):705–10.
Krakow D, Robertson SP, King LM, et al. Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet. 2004;36(4):405–10.
Poznanski AK. Punctate epiphyses: a radiological sign not a disease. Pediatr Radiol. 1994;24(6):418–24, 36.
White AL, Modaff P, Holland-Morris F, Pauli RM. Natural history of rhizomelic chondrodysplasia punctata. Am J Med Genet A. 2003;118A(4):332–42.
Braverman N, Steel G, Obie C, et al. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet. 1997;15(4):369–76.
Jeune M, Larbre F, Carron R, Couette I. La maladie congenitale des epiphyses pointillees ou calcinose fetale epiphysaire chondroystrophiante. Arch Fr Pediatr. 1953;10:914–42.
Roth SI, Jimenez JF, Husted S, Seibert JJ, Haynes DW. The histopathology of camptomelia (bent limbs). A dyschondrogenesis. Clin Orthop Relat Res. 1982;167:152–9.
Coscia MF, Bassett GS, Bowen JR, Ogilvie JW, Winter RB, Simonton SC. Spinal abnormalities in camptomelic dysplasia. J Pediatr Orthop. 1989;9(1):6–14.
Ray S, Bowen JR. Orthopaedic problems associated with survival in campomelic dysplasia. Clin Orthop Relat Res. 1984;185:77–82.
Spentchian M, Merrien Y, Herasse M, et al. Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat. 2003;22(1):105–6.
Hall CM, Elcioglu NH. Metatropic dysplasia lethal variants. Pediatr Radiol. 2004;34(1):66–74.
O’Sullivan MJ, McAllister WH, Ball RH, Teitelbaum SL, Swanson PE, Dehner LP. Morphologic observations in a case of lethal variant (type I) metatropic dysplasia with atypical features: morphology of lethal metatropic dysplasia. Pediatr Dev Pathol. 1998;1(5):405–12.
Shapiro F. Structural abnormalities of the epiphyses in skeletal dysplasias. In: JA Buckwalter ME, LJ Sandell, SB Trippel editors. Skeletal growth and development: clinical issues and basic science advances. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1998. p. 471–89.
Yang SS, Kitchen E, Gilbert EF, Rimoin DL. Histopathologic examination in osteochondrodysplasia. Time for standardization. Arch Pathol Lab Med. 1986;110(1):10–2.
MacCallum WG. Chondrodystrophia fetalis. Notes on the pathological changes in four cases. John Hopkins Hosp Bull. 1915; 26.
Thurston MN, Johnson DR, Kember NF. Cell kinetics of growth cartilage of achondroplastic (cn) mice. J Anat. 1985;140(Pt 3):425–34.
Shapiro F, Mulhern H, Weis MA, Eyre D. Rough endoplasmic reticulum abnormalities in a patient with spondyloepimetaphyseal dysplasia with scoliosis, joint laxity, and finger deformities. Ultrastruct Pathol. 2006;30(5):393–400.
Kim PS, Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev. 1998;19(2):173–202.
Sitia R, Braakman I. Quality control in the endoplasmic reticulum protein factory. Nature. 2003;426(6968):891–4.
Tsai B, Ye Y, Rapoport TA. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol. 2002;3(4):246–55.
Cooper RR, IV P Maynard JA. Pseudo-achondroplastic dwarfism: a rough-surfaced endoplasmic reticulum storage disorder. J Bone Joint Surg Am. 1973;55A:475–84.
Unger S, Hecht JT. Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments. Am J Med Genet. Winter. 2001;106(4):244–50.
Menger H, Mundlos S, Becker K, Spranger J, Zabel B. An unknown spondylo-meta-epiphyseal dysplasia in sibs with extreme short stature. Am J Med Genet. 1996;63(1):80–3.
Sillence DO, Horton WA, Rimoin DL. Morphologic studies in the skeletal dysplasias. Am J Pathol. 1979;96(3):813–70.
Gilbert-Barnes E, Langer LO Jr, Opitz JM, Laxova R, Sotelo-Arila C. Kniest dysplasia: radiologic, histopathological, and scanning electronmicroscopic findings. Am J Med Genet. 1996;63(1):34–45.
Shapiro F. Pediatric orthopedic deformities. San Diego: Elvesier/Academic Press; 2001.
Gilbert EF, Yang SS, Langer L, Opitz JM, Roskamp JO, Heidelberger KP. Pathologic changes of osteochondrodysplasia in infancy. A review. Pathol Annu. 1987;22(Pt 2):283–345.
Nogami H, Oohira A, Ozeki K, Oki T, Ogino T, Murachi S. Ultrastructure of cartilage in heritable disorders of connective tissue. Clin Orthop Relat Res. 1979;143:251–9.
Rimoin DL, Hollister DW, Lachman RS, et al. Histologic studies in the chondrodystrophies. Birth Defects Orig Artic Ser. 1974;10(12):274–95.
Rimoin DL, Silberberg R, Hollister DW. Chondro-osseous pathology in the chondrodystrophies. Clin Orthop Relat Res. 1976;114:137–52.
Spranger J, Maroteaux P. The lethal osteochondrodysplasias. Adv Hum Genet. 1990;19:1–103, 331–102.
Stanescu R, Stanescu V, Maroteaux P. Homozygous achondroplasia: morphologic and biochemical study of cartilage. Am J Med Genet. 1990;37(3):412–21.
Ponseti IV, Pedrini-Mille A, Pedrini V. Histological and chemical analysis of human iliac crest cartilage. I. Observations on trunk growth. Calcif Tissue Res. 1968;2(3):197–213.
Maynard JA, Ippolito EG, Ponseti IV, Mickelson MR. Histochemistry and ultrastructure of the growth plate in achondroplasia. J Bone Joint Surg Am. 1981;63(6):969–79.
Rimoin DL, Hughes GN, Kaufman RL, Rosenthal RE, McAlister WH, Silberberg R. Endochondral ossification in achondroplastic dwarfism. N Engl J Med. 1970;283(14):728–35.
Keith A. Studies on the anatomical changes which accompany certain growth-disorders of the human body. 1. The nature of the structural alterations in the disorder known as multiple exostoses. J Anat. 1920;54:101–15.
Ponseti IV. Skeletal growth in achondroplasia. J Bone Joint Surg Am. 1970;52(4):701–16.
Shapiro F. Light and electron microscopic abnormalities in diastrophic dysplasia growth cartilage. Calcif Tissue Int. 1992;51(4):324–31.
Stanescu V, Stanescu R, Maroteaux P. Pathogenic mechanisms in osteochondrodysplasias. J Bone Joint Surg Am. 1984;66(6):817–36.
Williams BR, Cranley RE. Morphologic observations on four cases of SED congenita. Birth Defects Orig Artic Ser. 1974;10(9):75–87.
Wasylenko MJ, Wedge JH, Houston CS. Metaphyseal chondrodysplasia, Schmid type. A defect of ultrastructural metabolism: case report. J Bone Joint Surg Am. 1980;62(4):660–3.
Cooper RR, Pedrini-Mille A, Ponseti IV. Metaphyseal dysostosis: a rough surfaced endoplasmic reticulum storage defect. Lab Invest. 1973;28(1):119–25.
Maynard JA, Ippolito EG, Ponseti IV, Mickelson MR. Histochemistry and ultrastructure of the growth plate in metaphyseal dysostosis: further observations on the structure of the cartilage matrix. J Pediatr Orthop. 1981;1(2):161–9.
Silveri CP, Kaplan FS, Fallon MD, Bayever E, August CS. Hurler syndrome with special reference to histologic abnormalities of the growth plate. Clin Orthop Relat Res. 1991;269:305–11.
Peterson L, Parkin J, Nelson A. Mucopolysaccharidosis type VII. A morphologic, cytochemical, and ultrastructural study of the blood and bone marrow. Am J Clin Pathol. 1982;78(4):544–8.
Maynard JA, Cooper RR, Ponseti IV. Morquio’s disease (mucopolysaccharidosis type IV). Ultrastructure of epiphyseal plates. Lab Invest. 1973;28(2):194–205.
Pazzaglia UE, Beluffi G, Castello A, Coci A, Zatti G. Bone changes of mucolipidosis II at different ages. Postmortem study of three cases. Clin Orthop Relat Res. 1992;276:283–90.
Maynard JA, Cooper RR, Ponseti IV. A unique rough surfaced endoplasmic reticulum inclusion in pseudoachondroplasia. Lab Invest. 1972;26(1):40–4.
Hall CM, Elcioglu NH, Shaw DG. A distinct form of spondyloepimetaphyseal dysplasia with multiple dislocations. J Med Genet. 1998;35(7):566–72.
Kozlowski K, Beighton P. Radiographic features of spondylo-epimetaphyseal dysplasia with joint laxity and progressive kyphoscoliosis. Review of 19 cases. Rofo. 1984;141(3):337–41.
Nishimura G, Honma T, Shiihara T, et al. Spondyloepimetaphyseal dysplasia with joint laxity leptodactylic form: clinical course and phenotypic variations in four patients. Am J Med Genet A. 2003;117A(2):147–53.
Tsirikos AI, Mason DE, Scott CI Jr, Chang WN. Spondyloepimetaphyseal dysplasia with joint laxity (SEMDJL). Am J Med Genet A. 2003;119A(3):386–90.
Reeder MM. Gamuts in bone, joint and spine radiology. Comprehensive lists of roentgen differential diagnosis. New York: Springer; 1993.
Kopits SE. Orthopedic complications of dwarfism. Clin Orthop Relat Res. 1976;114:153–79.
Tolo VT. Spinal disorders associated with skeletal dysplasias and metabolic diseases. In: Herkowitz HN, Garfin SR, Eismont FJ, Bell GR, Balderston RA, editors. Rothamn-simeone the spine, 6th ed. Philadelphia: Elsevier; 2011. Chapter 32, p. 608.
Lachman RS. The cervical spine in the skeletal dysplasias and associated disorders. Pediatr Radiol. 1997;27(5):402–8.
Svensson O, Aaro S. Cervical instability in skeletal dysplasia. Report of 6 surgically fused cases. Acta Orthop Scand. 1988;59(1):66–70.
Lipson SJ. Dysplasia of the odontoid process in Morquio’s syndrome causing quadriparesis. J Bone Joint Surg Am. 1977;59(3):340–4.
Wynne-Davies R. Instability of the upper cervical spine: Skeletal dysplasia group. Arch Dis Child. 1989;64:283–8.
Madigan R, Worrall T, McClain EJ. Cervical cord compression in hereditary multiple exostosis. Review of the literature and report of a case. J Bone Joint Surg Am. 1974;56(2):401–4.
Bedi A, Hensinger RN. Congenital anomalies of the cervical spine. In: Herkowitz HN, Garfin SR, Eismont FJ, Bell GR, Balderston RA, editors. Rothman-simeone the spine, 6th ed. Philadelphia: Elsevier; 2011. Chapter 30, p.524.
Hensinger RN. Kyphosis secondary to skeletal dysplasias and metabolic disease. Clin Orthop Relat Res. 1977;128:113–28.
Caffey J. Achondroplasia of pelvis and lumbosacral spine; some roentgenographic features. Am J Roentgenol Radium Ther Nucl Med. 1958;80(3):449–57.
Lutter LD, Longstein JE, Winter RB, Langer LO. Anatomy of the achondroplastic lumbar canal. Clin Orthop Relat Res. 1977;126:139–42.
Bethem D, Winter RB, Lutter L, et al. Spinal disorders of dwarfism. Review of the literature and report of eighty cases. J Bone Joint Surg Am. 1981;63(9):1412–25.
Crossan JF, Wynne-Davies R, Fulford GE. Bilateral failure of the capital femoral epiphysis: bilateral Perthes disease, multiple epiphyseal dysplasia, pseudoachondroplasia, and spondyloepiphyseal dysplasia congenita and tarda. J Pediatr Orthop. 1983;3(3):297–301.
Stelling FH. The hip in heritable conditions of connective tissue. Clin Orthop Relat Res. 1973;90:33–49.
Peretti G, Memeo A, Paronzini A, Marzorati S. Staged lengthening in the prevention of dwarfism in achondroplastic children: a preliminary report. J Pediatr Orthop B. 1995;4(1):58–64.
Penrose LS. Parental age and mutation. Lancet. 1955;269(6885):312–3.
Thompson JN Jr, Schaefer GB, Conley MC, Mascie-Taylor CG. Achondroplasia and parental age. N Engl J Med. 1986;314(8):521–2.
Wilkin DJ, Szabo JK, Cameron R, et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998;63(3):711–6.
Marie P. L’achondroplasie. Dans l’adolescence et l’age adulte. Press Med. 1900;8:17–23.
Shirley ED, Ain MC. Achondroplasia:manifestations and treatment. J Am Acad Orthop Surg. 2009;17:231–41.
Maroteaux P, Lamy M. Achondroplasia in man and animals. Clin Orthop Relat Res. 1964;33:91–103.
Knaggs RL. Achondroplasia. Br J Surg. 1927;15:10–39.
Nehme AM, Riseborough EJ, Tredwell SJ. Skeletal growth and development of the achondroplastic dwarf. Clin Orthop Relat Res. 1976;116:8–23.
Young ID. Achondroplasia: a case of neglect? Lancet. 1998;352(9145):1950–51.
Hecht JT, Francomano CA, Horton WA, Annegers JF. Mortality in achondroplasia. Am J Hum Genet. 1987;41(3):454–64.
Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI Jr. Medical complications of achondroplasia: a multicentre patient review. J Med Genet. 1998;35(9):705–12.
Tasker RC, Dundas I, Laverty A, Fletcher M, Lane R, Stocks J. Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study. Arch Dis Child. 1998;79(2):99–108.
Hecht JT, Horton WA, Reid CS, Pyeritz RE, Chakraborty R. Growth of the formane magnum in achondroplasia. Am J Med Genet. 1989;32:528–35.
Rimoin DL. Cervicomedullary junction compression in infants with achondroplasia: when to perform neurosurgical decompression. Am J Hum Genet. 1995;56(4):824–7.
Ryken TC, Menezes AH. Cervicomedullary compression in achondroplasia. J Neurosurg. 1994;81(1):43–8.
Pauli RM, Horton VK, Glinski LP, Reiser CA. Prospective assessment of risks for cervicomedullary-junction compression in infants with achondroplasia. Am J Hum Genet. 1995;56(3):732–44.
Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics. 1995; 95:443–51.
Uematsu S, Wang H, Kopits SE, Hurko O. Total craniospinal decompression in achondroplastic stenosis. Neurosurgery. 1994;35(2):250–57; discussion 257–58.
Lutter LD, Langer LO. Neurological symptoms in achondroplastic dwarfs–surgical treatment. J Bone Joint Surg Am. 1977;59(1):87–92.
Ain MC, Shirley ED, Pirouzmanesh A, Hariri A, Carson BS. Postlaminectomy kyphosis in the skeletally immature achondroplast. Spine. 2006;31:197–201.
Kopits SE. Thoracolumbar kyphosis and lumbosacral hyperlordosis in achondroplastic children. Basic Life Sci. 1998;48:241–55.
Bailey JA 2nd. Orthopaedic aspects of achondroplasia. J Bone Joint Surg Am. 1970;52(7):1285–301.
Bellus GA, McIntosh I, Szabo J, Aylsworth A, Kaitila I, Francomano CA. Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene. Ann N Y Acad Sci. 1996;785:182–7.
Glasgow JF, Nevin NC, Thomas PS. Hypochondroplasia. Arch Dis Child. 1978;53(11):868–72.
Specht EE, Daentl DL. Hypochondroplasia. Clin Orthop Relat Res. 1975;110:249–55.
Dahlqvist J, Orlen H, Matsson H, Dahl N, Lonnerholm T, Gustavson KH. Multiple epiphyseal dysplasia. Acta Orthop. 2009;80(6):711–5.
Lachman RS, Krakow D, Cohn DH, Rimoin DL. MED, COMP, multilayered and NEIN: an overview of multiple epiphyseal dysplasia. Pediatr Radiol. 2005;35(2):116–23.
Van Mourik JBA, Hamel BCJ, Mariman ECM. A large family with multiple epiphyseal dysplasia linked to COL9A2 gene. Am J Med Genet. 1998;77:234–40.
Ribbing S. Studien uber hereditare, multiple epiphysenstorungen. Acta Radiol Suppl. 1937;34:77–107.
Fairbank T. Dysplasia epiphysialis multiplex. Br J Surg. 1947;34(135):225–32.
Stanescu R, Stanescu V, Muriel MP, Maroteaux P. Multiple epiphyseal dysplasia, Fairbank type: morphologic and biochemical study of cartilage. Am J Med Genet. 1993;45(4):501–7.
Ingram RR. Early diagnosis of multiple epiphyseal dysplasia. J Pediatr Orthop. 1992;12(2):241–4.
Mouchet A, Belot J. La tarsomegalie. J Radiol Electrol. 1926;10:289–93.
Trevor D. Tarso-epiphysial aclasis; a congenital error of epiphysial development. J Bone Joint Surg Br. 1950;32-B(2):204–13.
Fairbank TJ. Dysplasia epiphysialis hemimelica (tarso-ephiphysial aclasis). J Bone Joint Surg Br. 1956;38-B(1):237–57.
Buckwalter JA, El-Khoury GY, Flatt AE. Dysplasia epiphysealis hemimelica of the ulna. Clin Orthop Relat Res. 1978;135:36–8.
Connor JM, Horan FT, Beighton P. Dysplasia epiphysialis hemimelica. A clinical and genetic study. J Bone Joint Surg Br. 1983;65(3):350–4.
Noyes FR, Kivi LP. Dysplasia epiphysealis hemimelica: a case simulating an intra-articular body. Clin Orthop Relat Res. 1972;86:175–7.
Rao SB, Roy DR. Dysplasia epiphysealis hemimelica. Upper limb involvement with associated osteochondroma. Clin Orthop Relat Res. 1994;307:103–9.
Cruz-Conde R, Amaya S, Valdivia P, Hernandez M, Calvo M. Dysplasia epiphysealis hemimelica. J Pediatr Orthop. 1984;4(5):625–9.
Skaggs DL, Moon CN, Kay RM, Peterson HA. Dysplasia epiphysealis hemimelica of the acetabulum. A report of two cases. J Bone Joint Surg Am. 2000;82(3):409–14.
Rosero VM, Kiss S, Terebessy T, Kollo K, Szoke G. Dysplasia epiphysealis hemimelica (Trevor’s disease): 7 of our own cases and a review of the literature. Acta Orthop. 2007;78(6):856–61.
Bahk WJ, Lee HY, Kang YK, Park JM, Chun KA, Chung YG. Dysplasia epiphysealis hemimelica: radiographic and magnetic resonance imaging features and clinical outcome of complete and incomplete resection. Skeletal Radiol. 2010;39(1):85–90.
Keret D, Spatz DK, Caro PA, Mason DE. Dysplasia epiphysealis hemimelica: diagnosis and treatment. J Pediatr Orthop. 1992;12(3):365–72.
Beighton P. Inherited disorders of the skeleton. Genetics in medicine and surgery series. 2 ed. Edinburgh: Churchill Livingstone; 1978.
Franco B, Meroni G, Parenti G, et al. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell. 1995;81(1):15–25.
Beighton P, Kozlowski K. Spondylo-epi-metaphyseal dysplasia with joint laxity and severe, progressive kyphoscoliosis. Skeletal Radiol. 1980;5(4):205–12.
Winter RB, Bloom BA. Spine deformity in spondyloepimetaphyseal dysplasia. J Pediatr Orthop. 1990;10(4):535–9.
Lamy M, Maroteaux P. Le nanisme diastrophique. La Presse Medicale. 1960;52:1977–80.
Hollister DW, Lachman RS. Diastrophic dwarfism. Clin Orthop Relat Res. 1976;114:61–9.
Langer LO Jr. Diastrophic dwarfism in early infancy. Am J Roentgenol Radium Ther Nucl Med. 1965;93:399–404.
Stover CN, Hayes JT, Holt JF. Diastrophic dwarfism. Am J Roentgenol Radium Ther Nucl Med. 1963;89:914–22.
Taybi H. Diastrophic dwarfism. Radiology. 1963;80:1–10.
Walker BA, Scott CI, Hall JG, Murdoch JL, McKusick VA. Diastrophic dwarfism. Medicine (Baltimore). 1972;51(1):41–59.
Herring JA. The spinal disorders in diastrophic dwarfism. J Bone Joint Surg Am. 1978;60(2):177–82.
Bethem D, Winter RB, Lutter L. Disorders of the spine in diastrophic dwarfism. J Bone Joint Surg Am. 1980;62(4):529–36.
Poussa M, Merikanto J, Ryoppy S, Marttinen E, Kaitila I. The spine in diastrophic dysplasia. Spine (Phila Pa 1976). 1991;16(8):881–87.
Remes VM, Marttinen EJ, Poussa MS, Helenius IJ, Peltonen JI. Cervical spine in patients with diastrophic dysplasia–radiographic findings in 122 patients. Pediatr Radiol. 2002;32(9):621–8.
Remes V, Poussa M, Peltonen J. Scoliosis in patients with diastrophic dysplasia: a new classification. Spine (Phila Pa 1976). 2001;26(15):1689–97.
Remes V, Tervahartiala P, Poussa M, Peltonen J. Thoracic and lumbar spine in diastrophic dysplasia: a clinical and magnetic resonance imaging analysis. Spine (Phila Pa 1976). 2001;26(2):187–95.
Matsuyama Y, Winter RB, Lonstein JE. The spine in diastrophic dysplasia. The surgical arthrodesis of thoracic and lumbar deformities in 21 patients. Spine (Phila Pa 1976). 1999;24(22):2325–31.
Jalanko T, Remes V, Peltonen J, Poussa M, Helenius I. Treatment of spinal deformities in patients with diastrophic dysplasia: a long-term, population based, retrospective outcome study. Spine (Phila Pa 1976). 2009;34(20):2151–57.
Ryoppy S, Poussa M, Merikanto J, Marttinen E, Kaitila I. Foot deformities in diastrophic dysplasia. An analysis of 102 patients. J Bone Joint Surg Br. 1992;74(3):441–4.
Remes V, Tervahartiala P, Helenius I, Peltonen J. Magnetic resonance imaging analysis of hip joint development in patients with diastrophic dysplasia. J Pediatr Orthop. 2002;22(2):212–6.
Weiner DS, Jonah D, Kopits S. The 3-dimensional configuration of the typical hip and knee in diastrophic dysplasia. J Pediatr Orthop. 2010;30(4):403–10.
Peltonen J, Remes V, Tervahartiala P. Early degeneration of the knee in diastrophic dysplasia: an MRI study. J Pediatr Orthop. 2003;23(6):722–6.
Spranger J, Wiedemann HR. Dysplasia spondyloepiphysaria congenita. Helv Paed Acta. 1996;21:598–611.
Spranger JW, Langer LO Jr. Spondyloepiphyseal dysplasia congenita. Radiology. 1970;94(2):313–22.
Stanescu R, Stanescu V, Bordat C, Maroteaux P. La dysplasie spondylo-epiphysaire congenitale et son heterogeneite. Arch Fr Pediatr. 1980:527–30.
Schantz K, Andersen PE Jr, Justesen P. Spondyloepiphyseal dysplasia tarda. Report of a family with autosomal dominant transmission. Acta Orthop Scand. 1988;59(6):716–9.
Miladi M, Elleuch MH, Sellami S, Douik M. Dysplasie spondylo-epiphysaire tardive avec arthropathies progressives: a propos de trois observations Internat Orthop. 1987;11:271–5.
Maroteaux P, Lamy M. La dysostose metaphysaire. Sem Hop Paris. 1958;34:1729–35.
Wynne-Davies R, Hall CM, Young ID. Pseudoachondroplasia: clinical diagnosis at different ages and comparison of autosomal dominant and recessive types. A review of 32 patients (26 kindreds). J Med Genet. 1986;23(5):425–34.
Whitley CB. The mucopolysaccharidoses. In: Beighton P, editor. McKusick’s heritable disorders of connective tissue. 5th ed. St. Louis: Mosby; 1993. p. 367–499.
Morquio L. Sur une forme de dystrophie osseuse familiale. Arch Med Enf. 1929;32:129–40.
Mikles M, Stanton RP. A review of Morquio syndrome. Am J Orthop (Belle Mead NJ). 1997;26(8):533–40.
Pizzutillo PD, Osterkamp JA, Scott CI Jr, Lee MS. Atlantoaxial instability in mucopolysaccharidosis type VII. J Pediatr Orthop. 1989;9(1):76–8.
Quack I, Vonderstrass B, Stock M, et al. Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet. 1999;65(5):1268–78.
Cooper SC, Flaitz CM, Johnston DA, Lee B, Hecht JT. A natural history of cleidocranial dysplasia. Am J Med Genet. 2001;104(1):1–6.
Lou Y, Javed A, Hussain S, et al. A Runx2 threshold for the cleidocranial dysplasia phenotype. Hum Mol Genet. 2009;18(3):556–68.
Yoshida T, Kanegane H, Osato M, et al. Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet. 2002;71(4):724–38.
Kim HJ, Nam SH, Park HS, et al. Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J Cell Physiol. 2006;207(1):114–22.
Zheng Q, Sebald E, Zhou G, et al. Dysregulation of chondrogenesis in human cleidocranial dysplasia. Am J Hum Genet. 2005;77(2):305–12.
Stickler GB, Belau PG, Farrell FJ, et al. Hereditary progressive arthro-ophthalmopathy. Mayo Clin Proc. 1965;40:433–55.
Stickler GB, Hughes W, Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet Med. 2001;3(3):192–6.
Snead MP, Yates JR. Clinical and molecular genetics of stickler syndrome. J Med Genet. 1999;36(5):353–9.
Leri A, Weill J. Une affection congenitale et symetrique du developpement osseux: la dyschondrosteose. Bull Mem Soc Med Hop Paris. 1929;53:1491–4.
Langer LO Jr. Dyschondrosteosis, a hereditable bone dysplasia with characteristic roentgenographic features. Am J Roentgenol Radium Ther Nucl Med. 1965;95:178–88.
Dawe C, Wynne-Davies R, Fulford GE. Clinical variation in dyschondrosteosis. A report on 13 individuals in 8 families. J Bone Joint Surg Br. 1982;64(3):377–81.
Grigelioniene G, Eklof O, Ivarsson SA, et al. Mutations in short stature homeobox containing gene (SHOX) in dyschondrosteosis but not in hypochondroplasia. Hum Genet. 2000;107(2):145–9.
Benito-Sanz S, Thomas NS, Huber C, et al. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis. Am J Hum Genet. 2005;77(4):533–44.
Madelung O. Die spontane subluxation der hand nach vorne. Verh Dtsch Gesell Chir. 1878;7:259.
Beals RK, Lovrien EW. Dyschondrosteosis and Madelung’s deformity. Report of three kindreds and review of the literature. Clin Orthop Relat Res. 1976;116:24–8.
Laurencikas E, Soderman E, Grigelioniene G, Hagenas L, Jorulf H. Metacarpophalangeal pattern profile analysis in Leri-Weill dyschondrosteosis. Acta Radiol. 2005;46(2):200–7.
Costa T, Ramsby G, Cassia F, et al. Grebe syndrome: clinical and radiographic findings in affected individuals and heterozygous carriers. Am J Med Genet. 1998;75(5):523–9.
Hunter AG, Thompson MW. Acromesomelic dwarfism: description of a patient and comparison with previously reported cases. Hum Genet. 1976;34(1):107–13.
Cope R, Beals RK, Bennett RM. The trichorhinophalangeal dysplasia syndrome: report of eight kindreds, with emphasis on hip complications, late presentations, and premature osteoarthrosis. J Pediatr Orthop. 1986;6(2):133–8.
Dunbar JD, Sussman MD, Aiona MD. Hip pathology in the trichorhinophalangeal syndrome. J Pediatr Orthop. 1995;15(3):381–5.
Jabs EW, Muller U, Li X, et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell. 1993;75(3):443–50.
Laville JM, Lakermance P, Limouzy F. Larsen’s syndrome: review of the literature and analysis of thirty-eight cases. J Pediatr Orthop. 1994;14(1):63–73.
Laville JM. Knee deformities in Larsen’s syndrome. J Pediatr Orthop. 1994;3:180–4.
Micheli LJ, Hall JE, Watts HG. Spinal instability in Larsen’s syndrome: report of three cases. J Bone Joint Surg Am. 1976;58(4):562–5.
Bicknell LS, Farrington-Rock C, Shafeghati Y, et al. A molecular and clinical study of Larsen syndrome caused by mutations in FLNB. J Med Genet. 2007;44(2):89–98.
Hermanns P, Unger S, Rossi A, et al. Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. Am J Hum Genet. 2008;82(6):1368–74.
Katz DA, Hall JE, Emans JB. Cervical kyphosis associated with anteroposterior dissociation and quadriparesis in Larsen’s syndrome. J Pediatr Orthop. 2005;25(4):429–33.
Luk KD, Yip DK. Congenital anteroposterior spinal dissociation in Larsen’s Syndrome: report on two operated cases with long-term follow-up. Spine (Phila Pa 1976). 15 2002;27(12):E296–300.
Ollier M. Dyschondroplasie. Lyon Med. 1900;93:23–4.
Ollier M. Sur une nouvelle affection: la dyschondroplasie. Rev De Chir. 1900;21:396.
Paterson DC, Morris LL, Binns GF, Kozlowski K. Generalized enchondromatosis. A case report. J Bone Joint Surg Am. 1989;71(1):133–40.
Fairbank HAT. Dyschondroplasia. J Bone Joint Surg Br. 1948;30:689–704.
Shapiro F. Ollier’s disease. an assessment of angular deformity, shortening, and pathological fracture in twenty-one patients. J Bone Joint Surg Am. 1982;64(1):95–103.
Chang S, Prados MD. Identical twins with Ollier’s disease and intracranial gliomas: case report. Neurosurgery. 1994;34(5):903–06; discussion 906.
Nakayama Y, Takeno Y, Tsugu H, Tomonaga M. Maffucci’s syndrome associated with intracranial chordoma: case report. Neurosurgery. 1994;34(5):907–09; discussion 909.
Bessel Hagen F. Ueber Knochen-und Gelenkanomalieen, insbesondere bei partiellem Riesenwuchs und bei multiplen cartilaginaren Exostosen. Arch Klin Chir. 1891;41:420–66, 505–52, 749–823.
Bethge JFJ. Hereditare, multiple Exostosen and ihre pathogenetische Deutung. Archiv Orthop Unfall-Chir. 1963;54:667–96.
Ehrenfried A. Multiple cartilaginous exostoses—hereditary deforming chondrodysplasia. J Am Med Assoc. 1915;64:1642–6.
Ehrenfried A. Hereditary deforming chondrodysplasia – multiple cartilaginous exostoses. J Am Med Assoc. 1917;68:502–8.
Gibney VP. Hereditary multiple exostosis: four cases with remarks. Am J Med Sci. 1876;72:73–80.
Jaffe HL. Hereditary multiple exostosis. Arch Path. 1943;36:335–57.
Lenormant C. Les troubles de croissance. Dans les exostoses osteogeniques et ler chondromes des os. Rev Orthop. 1905;6:193–233.
Ollier M. Exostoses osteogeniques multiples. Lyon Med. 1898;88:484–5.
Peterson HA. Multiple hereditary osteochondromata. Clin Orthop Relat Res. 1989;239:222–30.
Solomon L. Hereditary multiple exostosis. J Bone Joint Surg Am. 1963;45B:292–304.
Fairbank HAT. Diaphysial aclasis. J Bone Joint Surg Am. 1949;31B:105–13.
Hennekam RC. Hereditary multiple exostoses. J Med Genet. 1991;28(4):262–6.
Hospital Reports. Guy’s Hospital. Case of cartilagenous exostosis. Lancet II. 1825;91.
Shapiro F, Simon S, Glimcher MJ. Hereditary multiple exostoses. Anthropometric, roentgenographic, and clinical aspects. J Bone Joint Surg Am. 1979;61(6A):815–24.
Stieber JR, Dormans JP. Manifestations of hereditary multiple exostoses. J Am Acad Orthop Surg. 2005;13(2):110–20.
Wuyts W, Schmale GA, Chansky HA, Raskind WH. Hereditary multiple osteochondromas. Gene reviews® [Internet] 2000 Aug 3 [Updated 2013, Nov 21] In: Pagon RA, Adam MP, Ardinger HH et al, editors. University of Washington: Seattle WA.
Porter DE, Lonie L, Fraser M, et al. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br. 2004;86(7):1041–6.
Jager M, Westhoff B, Portier S, et al. Clinical outcome and genotype in patients with hereditary multiple exostoses. J Orthop Res. 2007;25(12):1541–51.
Bovee J. Multiple osteochondromas. Orphanet Journal of Rare Disease. 2008;3(3): doi:10.1186/1750-1172-1183-1183.
McCormick C, Leduc Y, Martindale D, et al. The putative tumour suppressor EXT1 alters the expression of cell-surface heparen sulfate. Nat Genet. 1998;19:158–61.
Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem. 1998;273(41):26265–8.
Jennes I, Pedrini E, Zuntini M, Mordenti M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L, Wuyts W. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat. 2009;30(12):1620–7.
McCormick C, Duncan G, Goutsos KT, Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA. 2000;97(2):668–73.
Virchow R. Uber multiple exostosen, mit vorlegung von praparaten. Berl Klin Woch. 1891;28:1082.
Langenskiold A. Normal and pathological bone growth in the light of the development of cartilaginous foci in chondrodysplasia. Acta Chir Scan. 1947;95:367–86.
Leveuf MJ. Le probleme de la croissance de l’os en longueur etudie a la lumiere de la maladie exostosique. Rev Orthop. 1946;32:5–14.
Ogden JA. Multiple hereditary osteochondromata. Report of an early case. Clin Orthop Relat Res. 1976;116:48–60.
Milgram JW. The origins of osteochondromas and enchondromas. A histopathologic study. Clin Orthop Relat Res. 1983;174:264–84.
Shapiro F, Ellis R. Experimental induction of osteochondromas. Orthopaedic Transactions. 1977;1(51).
Hwang SK, Park BM. Induction of osteochondromas by periosteal resection. Orthopedics. 1991;14(7):809–12.
Mansoar A, Beals RK. Multiple exostosis: a short study of abnormalities near the growth plate. J Pediatr Orthop B. 2007;16:363–5.
Weiner DS, Hoyt WA Jr. The development of the upper end of the femur in multiple hereditary exostosis. Clin Orthop Relat Res. 1978;137:187–90.
Porter DE, Benson MK, Hosney GA. The hip in hereditary multiple exostoses. J Bone Joint Surg Br. 2001;83(7):988–95.
Felix NA, Mazur JM, Loveless EA. Acetabular dysplasia associated with herediatry multiple exostoses. J bone Joint Surg [Br]. 1998;81-B:555–7.
Malagon V. Development of hip dysplasia in hereditary multiple exostosis. J Pediatr Orthop. 2001;21(2):205–11.
Nawata K, Teshima R, Minamizaki T, Yamamoto K. Knee deformities in multiple hereditary exostoses. A longitudinal radiographic study. Clin Orthop Relat Res. 1995;313:194–9.
Snearly WN, Peterson HA. Management of ankle deformities in multiple hereditary osteochondromata. J Pediatr Orthop. 1989;9(4):427–32.
Burgess RC, Cates H. Deformities of the forearm in patients who have multiple cartilaginous exostosis. J Bone Joint Surg Am. 1993;75(1):13–8.
Taniguchi K. A practical classification system for multiple cartilaginous exostosis in children. J Pediatr Orthop. 1995;15(5):585–91.
Arms DM, Strecker WB, Manske PR, Schoenecker PL. Management of forearm deformity in multiple hereditary osteochondromatosis. J Pediatr Orthop. 1997;17(4):450–4.
Stanton RP, Hansen MO. Function of the upper extremities in hereditary multiple exostoses. J Bone Joint Surg Am. 1996;78(4):568–73.
Masada K, Tsuyuguchi Y, Kawai H, Kawabata H, Noguchi K, Ono K. Operations for forearm deformity caused by multiple osteochondromas. J Bone Joint Surg Br. 1989;71(1):24–9.
Fogel GR, McElfresh EC, Peterson HA, Wicklund PT. Management of deformities of the forearm in multiple hereditary osteochondromas. J Bone Joint Surg Am. 1984;66(5):670–80.
Peterson HA. Deformities and problems of the forearm in children with multiple hereditary osteochondromata. J Pediatr Orthop. 1994;14(1):92–100.
Siffert RS, Levy RN. Correction of wrist deformity in diaphyseal aclasis by stapling. Report of a case. J Bone Joint Surg Am. 1965;47(7):1378–80.
Finidori G, Rigault P, Padovani JP. Growth disturbance of the forearm in multiple exostosis and dyschondroplasia (author’s transl). Chir Pediatr. 1979;20(2):143–8.
Irani RN, Petrucelli RC. Ulnar lengthening for negative ulnar variance in hereditary multiple osteochondromas. J Pediatr Orthop. 1993;1:143–7.
Akita S, Murase T, Yonenobu K, Shimada K, Masada K, Yoshikawa H. Long-term results of surgery for forearm deformities in patients with multiple cartilaginous exostoses. J Bone Joint Surg Am. 2007;89(9):1993–9.
Waters PM, Van Heest AE, Emans J. Acute forearm lengthenings. J Pediatr Orthop. 1997;17(4):444–9.
Rodgers WB, Hall JE. One-bone forearm as a salvage procedure for recalcitrant forearm deformity in hereditary multiple exostoses. J Pediatr Orthop. 1993;13(5):587–91.
Cardelia JM, Dormans JP, Drummond DS, Davidson RS, Duhaime C, Sutton L. Proximal fibular osteochondroma with associated peroneal nerve palsy: a review of six cases. J Pediatr Orthop. 1995;15(5):574–7.
Roach JW, Klatt JWB, Faulker ND. Involvement of the spine in patients with multiple hereditary exostoses. J Bone Joint Surg Am. 2009;91:1942–8.
Vasseur MA, Fabre O. Vascular complications of osteochondromes. J Vasc Surg. 2000;31(3):532–8.
Huvos AG. Multiple osteocartilaginous exostosis (hereditary multiple exostosis, diaphyseal aclasis). In: Saunders W, editor. In bone tumors. Diagnosis, treatment and prognosis. 2 ed. Philadelphia: Saunders. 1991; p. 264–284.
Black B, Dooley J, Pyper A, Reed M. Multiple hereditary exostoses. An epidemiologic study of an isolated community in Manitoba. Clin Orthop Relat Res. 1993;287:212–7.
Wicklund CL, Pauli RM, Johnston D, Hecht JT. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995;55(1):43–6.
Francannet C, Cohen-Tanugi A, Le Merrer M, Munnich A, Bonaventure J, Legeai-Mallet L. Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet. 2001;38(7):430–4.
Maroteaux P. La metachondromatose. Z Kinderheilk. 1971;109:246–61.
Keret D, Bassett GS. Avascular necrosis of the capital femoral epiphysis in metachondromatosis. J Pediatr Orthop. 1990;10(5):658–61.
Wenger DR, Birch J, Rathjen K, Tobin R, Billman G. Metachondromatosis and avascular necrosis of the femoral head: a radiographic and histologic correlation. J Pediatr Orthop. 1991;11(3):294–300.
Albers-Schonberg H. Rontgenbilder einer seltenen knocherenkrankung. Munch Med Wochenschr. 1904;51:365.
Shapiro F. Osteopetrosis. Current clinical considerations. Clin Orthop Relat Res. 1993;294:34–44.
Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int. 2009;84(1):1–12.
Kaibara N, Katsuki I, Hotokebuchi T, Takagishi K. Intermediate form of osteopetrosis with recessive inheritance. Skeletal Radiol. 1982;9(1):47–51.
Sly WS, Whyte MP, Sundaram V, et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med. 1985;313(3):139–45.
Bollerslev J. Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical and hormonal aspects. Endocr Rev. 1989;10:45–67.
Bollerslev J, Andersen PE Jr. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 1988;9(1):7–13.
Bollerslev J, Andersen PE Jr. Fracture patterns in two types of autosomal-dominant osteopetrosis. Acta Orthop Scand. 1989;60(1):110–2.
Del Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone. 2008;42(1):19–29.
Van Hul W, Bollerslev J, Gram J, et al. Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet. 1997;61:363–9.
Felix R, Hofstetter W, Cecchini MG. Recent developments in the understanding of the pathophysiology of osteopetrosis. Eur J Endocrinol. 1996;134(2):143–56.
Marks SC Jr, Schneider GB. Evidence for a relationship between lymphoid cells and osteoclasts: bone resorption restored in ia (osteopetrotic) rats by lymphocytes, monocytes and macrophages from a normal littermate. Am J Anat. 1978;152(3):331–41.
Milgram JW, Jasty M. Osteopetrosis. A morphological study of twenty-one cases. J Bone Joint Surg Am. 1982;64(6):912–29.
Shapiro F, Key LL, Anast C. Variable osteoclast appearance in human infantile osteopetrosis. Calcif Tissue Int. 1988;43(2):67–76.
Shapiro F, Glimcher MJ, Holtrop ME, Tashjian AH Jr, Brickley-Parsons D, Kenzora JE. Human osteopetrosis: a histological, ultrastructural, and biochemical study. J Bone Joint Surg Am. 1980;62(3):384–99.
Reeves JD, August CS, Humbert JR, Weston WL. Host defense in infantile osteopetrosis. Pediatrics. 1979;64(2):202–6.
Beard CJ, Key L, Newburger PE, et al. Neutrophil defect associated with malignant infantile osteopetrosis. J Lab Clin Med. 1986;108(5):498–505.
Frattini A, Orchard PJ, Sobacchi C, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet. 2000;25(3):343–6.
Kornak U, Kasper D, Bosl MR, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104(2):205–15.
Pata M, Heraud C, Vacher J. OSTM1 bone defect reveals an intercellular hematopoietic crosstalk. J Biol Chem. 2008;283(45):30522–30.
Sobacchi C, Frattini A, Guerrini MM, et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet. 2007;39(8):960–2.
Guerrini MM, Sobacchi C, Cassani B, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008;83(1):64–76.
Van Wesenbeeck L, Odgren PR, Coxon FP, et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest. 2007;117(4):919–30.
Venta PJ, Welty RJ, Johnson TM, Sly WS, Tashian RE. Carbonic anhydrase II deficiency syndrome in a Belgian family is caused by a point mutation at an invariant histidine residue (107 His—Tyr): complete structure of the normal human CA II gene. Am J Hum Genet. 1991;49(5):1082–90.
Del Fattore A, Peruzzi B, Rucci N, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet. 2006;43(4):315–25.
Frattini A, Pangrazio A, Susani L, et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res. 2003;18(10):1740–7.
Waguespack SG, Hui SL, Dimeglio LA, Econs MJ. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab. 2007;92(3):771–8.
Taranta A, Migliaccio S, Recchia I, et al. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol. 2003;162(1):57–68.
Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, et al. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet. 2009;124(6):561–77.
Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351(27):2839–49.
Adams BK. Scintigraphy in a patient with complicated osteopetrosis. Clin Nuc Med. 1988;14:323.
Bollerslev J, Anderson PEJ. Fracture patterns in 2 types of autosomal-dominant osteopetrosis. Acta Orthop Scand. 1989;6(60):110–2.
Cameron HU, Dewar FP. Degenerative osteoarthritis associated with osteopetrosis. Clin Orthop Relat Res. 1977;127:148–9.
Armstrong DG, Newfield JT, Gillespie R. Orthopedic management of osteopetrosis: results of a survey and review of the literature. J Pediatr Orthop. 1999;19(1):122–32.
Lehman RAW, Reeves JD, Wilson WB, Wesenberg RL. Neurologic complications of infantile osteopetrosis. Ann Neurol. 1977;2:378–84.
Haines SJ, Erickson DL, Wirtschafter JD. Optic nerve decompression for osteopetrosis in early childhood. Neurosurgery. 1988;23(4):470–5.
Key L, Carnes D, Cole S, et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med. 1984;310(7):409–15.
Key LL Jr, Rodriguiz RM, Willi SM, et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med. 1995;332(24):1594–9.
Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science. 1975;190(4216):784–5.
Coccia PF, Krivit W, Cervenka J, et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med. 1980;302(13):701–8.
Fischer A, Griscelli C, Friedrich W, et al. Bone marrow transplantation for immunodeficiencies and osteopetrosis, European survey 1968–1985. Lancet II. 1986:1080.
Kaplan FS, August CS, Fallon MD, Dalinka M, Axel L, Haddad JG. Successful treatment of infantile malignant osteopetrosis by bone-marrow transplantation. A case report. J Bone Joint Surg Am. 1988;70(4):617–23.
Solh H, Da Cunha AM, Giri N, et al. Bone marrow transplantation for infantile malignant osteopetrosis. J Pediatr Hematol Oncol. 1995;17(4):350–5.
Gerritsen EJ, Vossen JM, Fasth A, et al. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr. 1994;125(6 Pt 1):896–902.
Rappaport JM. Bone marrow transplantation. In: Nathan DG, Oski FA, editors. Hematology of infancy and childhood. Vol 1. 3 ed. Philadelphia: WB Saunders; 1987: p. 255.
Driessen GJ, Gerritsen EJ, Fischer A, et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 2003;32(7):657–63.
Villa A, Pangrazio A, Caldana E, et al. Prognostic potential of precise molecular diagnosis of Autosomal Recessive Osteopetrosis with respect to the outcome of bone marrow transplantation. Cytotechnology. 2008;58(1):57–62.
Frattini A, Blair HC, Sacco MG, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci USA. 2005;102(41):14629–34.
Meredith SC, Simon MA, Laros GS, Jackson MA. Pycnodysostosis. A clinical, pathological, and ultramicroscopic study of a case. J Bone Joint Surg Am. 1978;60(8):1122–7.
Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996;273(5279):1236–8.
Maroteaux P, Lamy M. Deux observations d’une affection osseuse condensante: la pycnodystose. Arch francaises ped. 1962;19:267–74.
Maroteaux P, Lamy M. La pycnodysostose. Presse Med. 1962;70:999–1002.
Fujita Y, Nakata K, Yasui N, et al. Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab. 2000;85(1):425–31.
Donnarumma M, Regis S, Tappino B, et al. Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online. Hum Mutat. 2007;28(5):524.
Nakase T, Yasui N, Hiroshima K, Ohzono K, Higuchi C, Shimizu N, Yoshikawa H. Surgical outcomes after treatment of fractures of femur and tibia in pycnodysostsis. Arch Orthop Trauma Surg. 2007;127(3):161–5.
Shuler SE. Pycnodysostosis. Arch Dis Childh. 1963;38:620–5.
Fratzl-Zelman N, Valenta A, Roschger P, et al. Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab. 2004;89(4):1538–47.
Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med. 1992;43:269–82.
van Dijk FS, Cobben JM, Kariminejad A, van Rijin RR, Pals G. Osteogenesis Imperfecta: a review with clinical examples. Mol Syndromol. 2011;2:1–20.
Looser E. Zur kenntnis der osteogenesis imperfecta congenita und tarda (sogenannte idiopathische osteopsathyrosis). Mitt aus den Grenz der Med Chir. 1906;15:160–207.
Seedorff KS. Osteogenesis imperfecta. A study of clinical features and heredity based on 55 Danish families comprising 180 affected members. Universitetsforlaget I Arhus. 1949.
Sillence D. Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop Relat Res. 1981;159:11–25.
Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet. 1984;17(2):407–23.
Glorieux FH, Rauch F, Plotkin H, et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15(9):1650–8.
Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002;17(1):30–8.
Ward LM, Rauch F, Travers R, et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 2002;31(1):12–8.
Barnes AM, Chang W, Morello R, et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med. 2006;355(26):2757–64.
Cabral WA, Chang W, Barnes AM, et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet. 2007;39(3):359–65.
Barnes AM, Carter EM, Cabral WA, et al. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med. 2010;362(6):521–8.
Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM. Classification of Osteogenesis Imperfecta revisited. Eur J Med Genet. Jan-Feb. 2010;53(1):1–5.
Daly K, Wisbeach A, Sanpera I Jr, Fixsen JA. The prognosis for walking in osteogenesis imperfecta. J Bone Joint Surg Br. 1996;78:477–80.
Burnei G, Vlad C, Georgescu I, Gavriliu TS, Dan D. Osteogenesis imperfecta: diagnosis and treatment. J Am Acad Orthop Surg. 2008;16(6):356–66.
Falvo KA, Root L, Bullough PG. Osteogenesis imperfecta: clinical evaluation and management. J Bone Joint Surg Am. 1974;56(4):783–93.
Kocher MS, Shapiro F. Osteogenesis imperfecta. J Am Acad Orthop Surg. 1998;6(4):225–36.
Knaggs RL. Osteogenesis imperfecta. Brit J Surg. 1924;11:737–59.
Smars G. Osteogenesis imperfecta in Sweden. Stockholm: Svenska Bokforlaget; 1961.
Marini JC, Cabral WA, Barnes AM. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res. 2010;339(1):59–70.
Marlowe A, Pepin MG, Byers PH. Testing for osteogenesis imperfecta in cases of suspected non-accidental injury. J Med Genet. 2002;39(6):382–6.
King JD, Bobechko WP. Osteogenesis imperfecta. An orthopaedic description and surgical review. J Bone Joint Surg Am. 1971;53B:72–89.
Spranger J, Cremin B, Beighton P. Osteogenesis imperfecta congenita. Features and prognosis of a heterogenous condition. Pediatr Radiol. 1982;12(1):21–7.
Beals RK, Horton W. Skeletal dysplasias: an approach to diagnosis. J Am Acad Orthop Surg. 1995;3(3):174–81.
Bachinger HP, Morris NP, Davis JM. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet. 1993;45(2):152–62.
Raghunath M, Bruckner P, Steinmann B. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta. J Mol Biol. 1994;236(3):940–9.
Tenni R, Valli M, Rossi A, Cetta G. Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. Am J Med Genet. 1993;45(2):252–6.
Roughley PJ, Rauch F, Glorieux FH. Osteogenesis imperfecta–clinical and molecular diversity. Eur Cell Mater. 30 2003;5:41–7; discussion 47.
Makareeva E, Mertz EL, Kuznetsova NV, et al. Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta. J Biol Chem. 2008;283(8):4787–98.
Persikov AV, Ramshaw JA, Brodsky B. Prediction of collagen stability from amino acid sequence. J Biol Chem. 2005;280(19):19343–9.
Marini JC, Forlino A, Cabral WA, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007;28(3):209–21.
Bodian DL, Madhan B, Brodsky B, Klein TE. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations. Biochemistry. 2008;47(19):5424–32.
Beck K, Chan VC, Shenoy N, Kirkpatrick A, Ramshaw JA, Brodsky B. Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine. Proc Natl Acad Sci USA. 2000;97(8):4273–8.
Van Dijk FS, Sillence DO. Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment. Am J Med Genet Part A. 2014;164A:1470–1481.
Bullough PG, Davidson DD, Lorenzo JC. The morbid anatomy of the skeleton in osteogenesis imperfecta. Clin Orthop Relat Res. 1981;159:42–57.
Casella JP, Stamp TCB, Ali SY. A morphological and ultrastructural study of bone in osteogenesis imperfecta. Calcif Tissue Int. 1996;58:155–65.
Cassella JP, Barber P, Catterall AC, Ali SY. A morphometric analysis of osteoid collagen fibril diameter in osteogenesis imperfecta. Bone. 1994;15(3):329–34.
Falvo KA, Bullough PG. Osteogenesis imperfecta: a histometric analysis. J Bone Joint Surg Am. 1973;55(2):275–86.
van der Harten HJ, Brons JT, Dijkstra PF, et al. Perinatal lethal osteogenesis imperfecta: radiologic and pathologic evaluation of seven prenatally diagnosed cases. Pediatr Pathol. 1988;8(3):233–52.
Sztrolovics R, Glorieux FH, Travers R, van der Rest M, Roughley PJ. Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. Bone. 1994;15(3):321–8.
Jaffe HL. The structure of bone. With particular reference to its fibrillar nature and the relation of function to internal architecture. Arch Surg. 1929;19:24–52.
Weidenreich F. Das Knochengewebe. In Handbuch der mikroskopischen anatomie des menschen. In: Mollendorff Wv, editor. Die Gewebe. Teil 2. Sturtzgewebe Knochengewebe Skeletsystem. Berlin: Springer; 1930: 394–406.
Smith JW. Collagen fibre patterns in mammalian bone. J Anat. 1960;94(Pt 3):329–44.
Giraud-Guille MM. Twisted plywood architecture of collagen fibrils in human compact bone osteons. Calcif Tissue Int. 1988;42(3):167–80.
Neville AC. Biology of fibrous composites. Development beyond the cell membrane. Cambridge, England: Cambridge University Press; 1993.
Moorefield WG Jr, Miller GR. Aftermath of osteogenesis imperfecta: the disease in adulthood. J Bone Joint Surg Am. 1980;62(1):113–9.
Paterson CR, McAllion S, Stellman JL. Osteogenesis imperfecta after the menopause. N Engl J Med. 1984;310(26):1694–6.
Gargan MF, Wisbeach A, Fixsen JA. Humeral rodding in osteogenesis imperfecta. J Pediatr Orthop. 1996;16(6):719–22.
Sofield HA, Millar EA. Fragmentation, realignment and intramedullary rod fixation of deformities of the long bones in children: a ten year appraisal. J Bone Joint Surg Am. 1959;41A:1371–91.
Williams PF. Fragmentation and rodding in osteogenesis imperfecta. J Bone Joint Surg Br. 1965;47:23–31.
Abulsaad M, Abdelrahman A. Modified Sofield-Millar operation: less invasive surgery of lower limbs in osteogenesis imperfecta. Int Orthop. 2009;33(2):527–32.
Khoshhal KI, Ellis RD. Effect of lower limb Sofield procedure on ambulation in osteogenesis imperfecta. J Pediatr Orthop. 2001;21(2):233–5.
Gamble JG, Strudwick WJ, Rinsky LA, Bleck EE. Complications of intramedullary rods in osteogenesis imperfecta: Bailey-Dubow rods versus nonelongating rods. J Pediatr Orthop. 1988;8(6):645–9.
Bailey RW, Dubow HI. Evolution of the concept of an extensible nail accommodating to normal longitudinal bone growth: clinical considerations and implications. Clin Orthop Relat Res. 1981;159:157–70.
Marafioti RL, Westin GW. Elongating intramedullary rods in the treatment of osteogenesis imperfecta. J Bone Joint Surg Am. 1977;59(4):467–72.
Bailey RW. Further clinical experience with the extensible nail. Clin Orthop Relat Res. 1981;159:171–6.
Rodriguez RP, Bailey RW. Internal fixation of the femur in patients with osteogenesis imperfecta. Clin Orthop Relat Res. 1981;159:126–33.
Lang-Stevenson AI, Sharrard WJ. Intramedullary rodding with Bailey-Dubow extensible rods in osteogenesis imperfecta. An interim report of results and complications. J Bone Joint Surg Br. 1984;66(2):227–32.
Jerosch J, Mazzotti I, Tomasevic M. Complications after treatment of patients with osteogenesis imperfecta with a Bailey-Dubow rod. Arch Orthop Trauma Surg. 1998;117(4–5):240–5.
Zionts LE, Ebramzadeh E, Stott NS. Complications in the use of Bailey-Dubow extensible nail. Clin Orthop Relat Res. 1998;366:186–95.
Wilkinson JM, Scott BW, Clarke AM, Bell MJ. Surgical stabilisation of the lower limb in osteogenesis imperfecta using the Sheffield telescopic intramedullary rod system. J Bone Joint Surg Am. 1998;80B:999–1004.
Nicolaou N, Bowe JD, Wilkinson JA, Fernandes JA, Bell MJ. Use of the Sheffield telescopic intramedullary rod system for the management of osteogenesis imperfecta: clinical outcomes at an average follow-up of nineteen years. J Bone Joint Surg Am. 2011;93:1994–2000.
Cho TJ, Choi IH, Chung CY, Yoo WJ, Lee KS, Lee DY. Interlocking telescopic rod for patients with osteogenesis imperfecta. J Bone Joint Surg Am. 2007;89(5):1028–35.
Mulpuri K, Joseph B. Intramedullary rodding in osteogenesis imperfecta. J Pediatr Orthop. 2000;20(2):267–73.
Chockalingam S, Bell MJ. Technique of exchange of Sheffield telescopic rod system. J Pediatr Orthop. 2002;22(1):117–9.
Fassier F, Glorieux FH. Osteogenesis Imperfecta. Elsevier SAS (Paris). Surg Tech Orthop Traumatol. 55-050-D-30. 2003; 8 pp.
Pega Medical QC. Fassier-Duval telescopic IM SYSTEM. Surg. Tech. 2009;1:1–19.
Garcia-German D, Parra Garcia J, Bueno Sanchez A, Fernandez Fernandez-Arroyo A. Intramedullary telescopic nailing with Fassier-Duval rod in osteogenesis imperfecta. J Bone Joint Surg [Br]. 2009;91-B(SUPP_1):58.
Mickel T. Outcomes and complications of skeletally immature patients treated with elongating Fassier-Duval telescopic rods: a retrospective review. 2010 Annual Meeting: American Academy of Pediatrics; 2010.
Ruck J, Dahan-Oliel N, Montpetit K, Rauch F, Fassier F. Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: funtional outcomes at one year. J Child Orthop. 2011;5:217–24.
Birke O, Davies N, Latimer M, Little DG, Bellemore M. Experience with the Fassier-Duval telescopic rod:first 24 consecutive cases with a minimum of 1-year follow-up. J Pediatr Orthop. 2011;31:458–64.
Metaizeau J. L’embrochage centro-medullaire coulissant: application au traitement des formes graves d’osteogenese imparfaite. Chir Pediatr. 1987;28:240–3.
Boutaud B, Laville JM. Elastic sliding central medullary nailing with osteogenesis imperfecta. Fourteen cases at eight years follow-up. Rev Chir Orthop Reparatrice Appar Mot. 2004;90(4):304–11.
Luhmann SJ, Sheridan JJ, Capelli AM, Schoenecker PL. Management of lower-extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: a 20-year experience. J Pediatr Orthop. 1998;18(1):88–94.
Fassier F, Sardar Z, Aarabi M, Odent T, Haque T, Hamdy R. Results and complications of a surgical technique for correction of coxa vara in children with osteopenic bones. J Pediatr Orthop. 2008;28(8):799–805.
Hanscom DA, Bloom BA. The spine in osteogenesis imperfecta. Orthop Clin North Am. 1988;19(2):449–58.
Sawin PD, Menezes AH. Basilar invagination in osteogenesis imperfecta and related osteochondrodysplasias: medical and surgical management. J Neurosurg. 1997;86(6):950–60.
Stott NS, Zionts LE. Displaced fractures of the apophysis of the olecranon in children who have osteogenesis imperfecta. J Bone Joint Surg Am. 1993;75(7):1026–33.
Albright JA. Systemic treatment of osteogenesis imperfecta. Clin Orthop Relat Res. 1981;159:88–96.
Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339(14):947–52.
Castillo H, Samon-Fang L. Effects of Biphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol. 2008;51:17–29.
Rauch F, Glorieux FH. Osteogenesis imperfecta, current and future medical treatment. Am J Med Genet C Semin Med Genet. 2005;139C(1):31–7.
Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377–85.
Phillipi CA, Remmington T, Steiner RD. Biphosphonate therapy for osteogenesis imperfecta (Cochrane Collaborative Review). Wiley: Hoboken N.J. 2009.
Rauch F, Travers R, Glorieux FH. Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy. J Clin Endocrinol Metab. 2006;91(2):511–6.
Forin V, Arabi A, Guigonis V, Filipe G, Bensman A, Roux C. Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study. Joint Bone Spine. 2005;72(4):313–8.
Devogelaer JP, Malghem J, Maldague B, Nagant de Deuxchaisnes C. Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta. Skeletal Radiol. 1987;16(5):360–3.
Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res. 2004;19(11):1779–86.
Ward LM, Rauch F, Whyte MP, et al. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab. 2011;96(2):355–64.
Rauch F, Munns CF, Land C, Cheung M, Glorieux FH. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res. 2009;24(7):1282–9.
Marini JC. Do bisphosphonates make children’s bones better or brittle? N Engl J Med. 2003;349(5):423–6.
Pereira RF, Halford KW, O’Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA. 1995;92(11):4857–61.
Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276(5309):71–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Shapiro, F. (2016). Skeletal Dysplasias. In: Pediatric Orthopedic Deformities, Volume 1. Springer, Cham. https://doi.org/10.1007/978-3-319-20529-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-20529-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20528-1
Online ISBN: 978-3-319-20529-8
eBook Packages: MedicineMedicine (R0)